OPRT has addressed previous concerns by repaying costly term loans and reducing its blended cost of debt from 8.6% to 6.3%. Credit quality has improved with 30-day delinquencies at their lowest since late 2021 and projected charge-offs for 2026 expected to hit a record low. Despite a 60% stock rally, shares trade below book value and at a discount to peers on forward P/E, prompting an upgrade to Buy with a new small position initiated. These changes reflect stronger financial health and positive outlook for the company.
Macy's reported Q1 earnings per share of $0.40, exceeding the $0.37 estimate, with revenue of $4.87 billion beating expectations. Growth was driven by strong sales in Bloomingdale's, Bluemercury, and Macy's stores. The company raised its full-year ne...
Arete Research downgraded Uber's stock from Buy to Neutral with a $74 price target, citing an expected 64.95% drop in earnings per share to $1.09 despite 9.6% revenue growth to $14.76 billion. Uber faces new competition from Tesla's Cybercab, which o...
Wealthfront Corporation reported better-than-expected Q2 2026 earnings with $0.10 EPS versus $0.08 estimated and revenue of $91.87 million surpassing $91.53 million estimates. The company’s total platform assets grew 12% year-over-year to $99 billion...
Kristin Ess Hair, a popular haircare brand under Maesa, has launched its products on REVOLVE, a leading fashion retailer targeting Gen Z and Millennials. The collection includes over 30 items such as the viral Signature Hair Gloss and The One Shampoo...
ADARx Pharmaceuticals is pursuing an IPO to raise capital for its RNA-targeted therapy pipeline, focusing on serious liver and non-liver diseases. Its lead drug, Onvuzosiran, is in Phase 3 trials for hereditary angioedema, with key data expected by t...
